Abstract
The physicochemical properties and crystal structures of the crystalline salts formed by the interaction of an achiral anion, salicylate, with homochiral and racemic ephedrinium and pseudoephedrinium cations were determined. The interaction of ephedrinium or pseudoephedrinium with salicylate in aqueous solution yielded crystalline salts with the notable exception of homochiral ephedrinium. Evaporation of the solvent from solutions of homochiral ephedrine and salicyclic acid in various organic solvents, as well as grinding together solid homochiral ephedrine and solid salicylic acid, yielded viscous semisolids suggesting that homochiral ephedrinium salicylate has a low melting point and/or a high aqueous solubility. Mixing of the two viscous solids, obtained by grinding each of the opposite enantiomers of ephedrine with equimolar salicylic acid, resulted in the formation of racemic ephedrine and subsequently, upon heating, in the formation of racemic ephedrinium salicylate. While racemic ephedrinium salicylate exists as a crystalline compound (P21/n space group) with an equal number of opposite enantiomers in the unit cell, its diastereomer, racemic pseudoephedrinium salicylate, exists as a conglomerate, i.e. a physical mixture, of the homochiral crystals of the opposite enantiomers (each P21 space group). The inability of homochiral ephedrinium to exist as a crystalline salicylate salt at 20–25°C is attributed to its high energy conformation and/or to the poor packing of homochiral ephedrinium salicylate molecules in the crystal lattice.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
S. N. Berge, L. D. Bighley and D. C. Monkhouse. Pharmaceutical salts. J. Pharm. Sci. 66:1–19 (1977).
P. L. Gould. Salt selection for basic drugs. Int. J. Pharm. 33:201–217 (1986).
O. Wallach. Über gebromte Derivate der Carvonreihe. Liebigs Ann. Chem. 286:140 (1895).
C. Pratt-Brock, W. B. Schweizer and J. D. Dunitz. On the validity of Wallach's rule: On the density and stability of racemic crystals compared with their chiral counterparts. J. Am. Chem. Soc. 113:9811–9820 (1991).
J. Jacques, M. Leclerecq and M. J. Brienne. La formation de sels augmente-t-elle la fréquence des dédoublements spontanés? Tetrahedron 37:1727–1733 (1981).
J. Jacques, A. Collet, A. and S. H. Wilen. Enantiomers, Racemates and Resolutions, John Wiley & Sons: New York, 1981, pp 32–33, 81, 217–239, 423–435.
H. G. Brittain. Crystallographic consequences of molecular dissymmetry. Pharm. Res. 7:683–689 (1990).
S. P. Duddu. Implications of Chirality of Drugs and Excipients in Physical Pharmacy, Ph.D. thesis, University of Minnesota, Minneapolis, MN, 1993, pp 67–104.
D. T. Cromer, J. T. Waber. International Tables for X-ray Crystallography, vol. IV, Kynoch, Birmingham, England, 1974, Table 2.2 A.
J. A. Ibers and W. C. Hamilton. Dispersion corrections and crystal structure refinements. Acta Crystallogra. 17:781–782 (1964).
D. T. Cromer. International Tables for X-ray Crystallography, Vol. IV, Kynoch, Birmingham, England, 1974, Table 2.3.1.
A. I. Kitaigorodskii. Molecular Crystals and Molecules, Academic Press: New York, 1973.
S. P. Duddu and D. J. W. Grant. Formation of the racemic compound of ephedrine base from a physical mixture of its enantiomers in the solid, liquid, solution or vapor state. Pharm. Res. 9:1083–1091 (1992).
R. Bergin. Refinement of structure of (−)-ephedrine hydrochloride. Acta Cryst. B27:381–386 (1971).
A. Gorman, O. R. Gould, A. M. Gray, P. Taylor and M. D. Walkinshaw. Asymmetric resolution and molecular recognition. Part 2. The crystal structures of ephedrine-N-benzyloxy-carbonyl-L-leucine and ephedrine-N-acetyl-L-valine. Chem. Soc. Perkin. Trans. II:739–746 (1986).
H.-J. Gais and K. L. Lukas. Enantioselective and enantioconvergent syntheses of building blocks of cyclopentanoid natural products. Angew. Chem., Int. Ed. Engl. 23:142–143 (1984).
M. Mathew and G. J. Palenik. The crystal and molecular structures of (+)-pseudoephedrine and (+)-pseudoephedrine hydrochloride. Acta Cryst. B33:1016–1022 (1977).
R. A. Hearn and C. E. Bugg. The crystal structure of (−)-ephedrine dihydrogen phosphate. Acta Cryst. B28:3662–3667 (1972).
R. A. Hearn, G. R. Freeman and C. E. Bugg. Conformational and phosphate binding properties of phenylethanolamines. Crystal structure of ephedrine monohydrogen phosphate monohydrate. J. Am. Chem. Soc. 95:7150–7154 (1973).
L. B. Kier. The preferred conformations of ephedrine isomers and the nature of the alpha adrenergic receptor. J. Pharmacol. Exp. Ther. 164:75–81 (1968).
P. S. Portoghese. Stereochemical studies on medicinal agents. IV. Conformational analysis of ephedrine isomers and related compounds. J Med. Chem.. 10:1057–1063 (1961).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Duddu, S.P., Grant, D.J.W. Effects of Configuration Around the Chiral Carbon Atoms on the Crystal Properties of Ephedrinium and Pseudoephedrinium Salicylates. Pharm Res 11, 1549–1556 (1994). https://doi.org/10.1023/A:1018945401484
Issue Date:
DOI: https://doi.org/10.1023/A:1018945401484